Among these differential expressions of genes, CDK6 was finally selected for further study (Figure 4B) because CDK6, a vital modifier of the cell cycle, is indispensable for the initiation and maintenance of MF9‐rearranged leukaemia. Here, CDK6 is linked to leukemia.